| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0009 |